日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies

NEXUS:一项针对亚洲晚期/转移性实体恶性肿瘤患者的selinexor联合nivolumab和ipilimumab的I期剂量递增研究

R Choo, Joan; Jeraj, Santhiay Nathan; Sundar, Raghav; Yong, Wei Peng; Lee, Matilda; Huang, Yiqing; Asokumaran, Yugarajah; Chan, Gloria H J; Ngoi, Natalie Y L; Wong, Andrea L A; Soo, Ross A; Chee, Cheng Ean; Lim, Joline S J; Goh, Boon Cher; Lee, Soo Chin; Tan, David S P

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit

CD137L-DC-EBV-VAX 树突状细胞疗法治疗局部复发或转移性鼻咽癌是安全的,并具有临床益处

Emily Nickles, Bhushan Dharmadhikari, Li Yating, Robert J Walsh, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Ling-Zhi Wang, Yvonne Ang, Yugarajah Asokumaran, Wan Qin Chong, Yiqing Huang, Kwok Seng Loh, Joshua Tay, Ross Soo, Mickey Koh, Liam Pock Ho, Marieta Chan, Madelaine Niam, Melissa Soh, Yen Hoon

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer

在III期非小细胞肺癌同步放化疗后使用度伐利尤单抗进行巩固治疗的真实世界经验

Huang, Yiqing; Zhao, Joseph J; Soon, Yu Yang; Wong, Alvin; Aminkeng, Folefac; Ang, Yvonne; Asokumaran, Yugarajah; Low, Jia Li; Lee, Matilda; Choo, Joan R E; Chan, Gloria; Kee, Adrian; Tay, Sen Hee; Goh, Boon Cher; Soo, Ross A

Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors-Navigating the Radiologic Potpourri

肾细胞癌免疫检查点抑制剂治疗的非典型反应模式——放射学杂烩的探索

Wong, Alvin; Vellayappan, Balamurugan; Cheng, Lenith; Zhao, Joseph J; Muthu, Vaishnavi; Asokumaran, Yugarajah; Low, Jia-Li; Lee, Matilda; Huang, Yi-Qing; Kumarakulasinghe, Nesaretnam Barr; Ngoi, Natalie; Leong, Cheng-Nang; Chua, Wynne; Thian, Yee-Liang